Paraprotein levels in assessing effectiveness of polychemotherapy plus selective plasma exchange for multiple myeloma patients.

被引：0
|
作者：
Lysenko, Irina B.
Guskova, Nailya
Kit, Oleg Ivanovich
Ushakova, Natalya Dmitrievna
Golomeeva, Nadezhda
Zuderman, Natalia
Guskova, Ekaterina
Nozdricheva, Anastasia
Abakumova, Svetlana V.
Donskaya, Aliya K.
Gusareva, Marina A.
Avanesova, Kristina
Torpudzhyan, Izabella
Tselishcheva, Irina V.
Zakharchenko, Viktoria
Belgova, Svetlana V.
Gornostaeva, Ekaterina
机构：
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷
关键词：
D O I：
10.1200/JCO.2017.35.15_suppl.e19511
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e19511
引用
收藏
页数：5
相关论文
共 50 条
  • [41] Higher levels of genomic complexity correlates with an advanced plasma cell differentiation status in newly diagnosed multiple myeloma patients
    Martello, Marina
    Termini, Rosalinda
    Borsi, Enrica
    Solli, Vincenza
    Poletti, Andrea
    Pantani, Lucia
    Rocchi, Serena
    Mancuso, Katia
    Zamagni, Elena
    Tacchetti, Paola
    Arpinati, Mario
    Chirumbolo, Gabriella
    Testoni, Nicoletta
    Marzocchi, Giulia
    Martinelli, Giovanni
    Cavo, Michele
    Terragna, Carolina
    CANCER RESEARCH, 2019, 79 (13)
  • [42] Lactate metabolism in clonal plasma cells and its therapeutic implications in multiple myeloma patients with elevated serum LDH levels
    Chawla, Yogesh
    Anderson, Emilie I.
    Smith, Matthew
    Jain, Sonia
    Evans, Laura A.
    Neff, Jadee
    Jang, Jin Sung
    Rosario, Isas K. Vazquez
    Jevremovic, Dragan
    Petterson, Xuan-Mai
    Sebastian, Sinto
    Fonseca, Rafael
    Kumar, Shaji K.
    Hitosugi, Taro
    Gonsalves, Wilson I.
    CANCER & METABOLISM, 2025, 13 (01)
  • [43] Cost-effectiveness of lenalidomide plus dexamethasone vs bortezomib plus melphalan and prednisone in transplant-ineligible US patients with newly-diagnosed multiple myeloma
    Usmani, S. Z.
    Cavenagh, J. D.
    Belch, A. R.
    Hulin, C.
    Basu, S.
    White, D.
    Nooka, A.
    Ervin-Haynes, A.
    Yiu, W.
    Nagarwala, Y.
    Berger, A.
    Pelligra, C. G.
    Guo, S.
    Binder, G.
    Gibson, C. J.
    Facon, T.
    JOURNAL OF MEDICAL ECONOMICS, 2016, 19 (03) : 243 - 258
  • [44] Plasma cell-free DNA chromosomal instability score as early predictor to monitor tumor burden in response to therapeutic in multiple myeloma patients.
    Du, Juan
    Jia, Yanchun
    Qiang, Wanting
    Lu, Jing
    Li, Lu
    Jiang, Hua
    Qian Ziliang
    Fu, Weijun
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [45] Relationship between bone marrow angiogenesis and plasma cell infiltration and serum β2-microglobulin levels in patients with multiple myeloma
    O. Sezer
    K. Niemöller
    C. Jakob
    I. Zavrski
    U. Heider
    J. Eucker
    O. Kaufmann
    K. Possinger
    Annals of Hematology, 2001, 80 : 598 - 601
  • [46] Relationship between bone marrow angiogenesis and plasma cell infiltration and serum β2-microglobulin levels in patients with multiple myeloma
    Sezer, O
    Niemöller, K
    Jakob, C
    Zavrski, I
    Heider, U
    Eucker, J
    Kaufmann, O
    Possinger, K
    ANNALS OF HEMATOLOGY, 2001, 80 (10) : 598 - 601
  • [47] Plasma Levels of Osteopontin and Vascular Endothelial Growth Factor in Association with Clinical Features and Parameters of Tumor Burden in Patients with Multiple Myeloma
    Valkovic, Toni
    Babarovic, Emina
    Lucin, Ksenija
    Stifter, Sanja
    Aralica, Merica
    Pecanic, Sanja
    Seili-Bekafigo, Irena
    Duletic-Nacinovic, Antica
    Nemet, Damir
    Jonjic, Nives
    BIOMED RESEARCH INTERNATIONAL, 2014, 2014
  • [48] COST-EFFECTIVENESS ANALYSIS OF IXAZOMIB PLUS LENALIDOMIDE-DEXAMETHASONE VERSUS DARATUMUMAB PLUS LENALIDOMIDEDEXAMETHASONE IN MULTIPLE MYELOMA PATIENTS RECEIVED MORE THAN ONE PRIOR TREATMENT IN CHINA
    Zhao, X.
    Feng, Y.
    Zhu, L.
    Liu, J.
    VALUE IN HEALTH, 2020, 23 : S442 - S442
  • [49] Cost-Effectiveness of Daratumumab Plus Lenalidomide Plus Dexamethasone Versus Lenalidomide Plus Dexamethasone for Treatment of Patients with Multiple Myeloma Who Have Received at Least One Prior Therapy: An Analysis of the Pollux Trial
    Maiese, Eric M.
    Graham, Christopher N.
    Hawe, Emma
    Le Moine, Jean-Gabriel
    Abraham, Ivo
    Senbetta, Mekre
    BLOOD, 2017, 130
  • [50] Cost-effectiveness of lenalidomide plus low-dose dexamethasone for newly diagnosed multiple myeloma patients ineligible for stem cell transplantation in China
    Lu, Jin
    Chen, Wendong
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2019, 8 (12) : 979 - 992
12345